Detalhe da pesquisa
1.
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.
Lancet
; 403(10435): 1460-1471, 2024 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38554725
2.
Disparate Outcomes, Biologic and Therapeutic Differences in Pediatric versus Adult Patients with Ewing Sarcoma.
Oncology
; 102(1): 1-8, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37598679
3.
Outcome of Patients With Malignant Peripheral Nerve Sheath Tumors Enrolled on Sarcoma Alliance for Research Through Collaboration (SARC) Phase II Trials.
Oncologist
; 28(5): 453-459, 2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36724001
4.
Integrative clinical genomics of metastatic cancer.
Nature
; 548(7667): 297-303, 2017 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28783718
5.
OER-073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma.
Cancer
; 128(19): 3516-3522, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35942596
6.
Giant Cell Tumor of Bone: Effect of Longer Dosing Intervals of Denosumab on Tumor Control and Bone-related Complications.
Oncologist
; 27(7): 595-599, 2022 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35589095
7.
NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022.
J Natl Compr Canc Netw
; 20(11): 1204-1214, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36351335
8.
Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(7): 815-833, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35830886
9.
A randomized, open-label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft-tissue sarcoma.
Cancer
; 127(6): 894-904, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33231866
10.
Health-related quality of life and pain with selinexor in patients with advanced dedifferentiated liposarcoma.
Future Oncol
; 17(22): 2923-2939, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33855868
11.
Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network.
Cancer
; 126(1): 98-104, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31536651
12.
NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021.
J Natl Compr Canc Netw
; 18(12): 1604-1612, 2020 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33285515
13.
Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study.
Lancet Oncol
; 20(12): 1719-1729, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31704134
14.
Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 16(5): 536-563, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29752328
15.
Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial.
Lancet Oncol
; 18(8): 1089-1103, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28651927
16.
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial.
Lancet Oncol
; 18(11): 1493-1501, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28988646
17.
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor.
Cancer
; 123(1): 90-97, 2017 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27696380
18.
SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcoma.
Cancer
; 122(6): 868-74, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26710211
19.
SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy.
BMC Cancer
; 16: 663, 2016 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27544129
20.
Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 14(6): 758-86, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27283169